Gilead Sciences, Inc. (NASDAQ:GILD) Confront Natco On Sovaldi Patent In India USTrade Voice Dallas, Texas 04/11/2014 (ustradevoice) – India's Natco Pharma once again challenges the U.S. drug maker Gilead Sciences, Inc. (NASDAQ:GILD) for its new drug Sovaldi patent. The Company asked ... The drug is successful in liver diseases. Patent issue. |
